Estrogen receptor beta agonist enhances temozolomide sensitivity of glioma cells by inhibiting PI3K/AKT/mTOR pathway | |
Liu, Xiaoyang; Wang, Libo; Chen, Jiajun; Ling, Qi; Wang, Hongfei; Li, Shilin; Li, Liming; Yang, Shuping; Xia, Mingying; Jing, Ling | |
刊名 | MOLECULAR MEDICINE REPORTS |
2015 | |
卷号 | 11期号:2 |
关键词 | temozolomide resistance estrogen receptor beta liquiritigenin PI3K/AKT/mTOR |
ISSN号 | 1791-2997 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4870607 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Liu, Xiaoyang,Wang, Libo,Chen, Jiajun,et al. Estrogen receptor beta agonist enhances temozolomide sensitivity of glioma cells by inhibiting PI3K/AKT/mTOR pathway[J]. MOLECULAR MEDICINE REPORTS,2015,11(2). |
APA | Liu, Xiaoyang.,Wang, Libo.,Chen, Jiajun.,Ling, Qi.,Wang, Hongfei.,...&Jing, Ling.(2015).Estrogen receptor beta agonist enhances temozolomide sensitivity of glioma cells by inhibiting PI3K/AKT/mTOR pathway.MOLECULAR MEDICINE REPORTS,11(2). |
MLA | Liu, Xiaoyang,et al."Estrogen receptor beta agonist enhances temozolomide sensitivity of glioma cells by inhibiting PI3K/AKT/mTOR pathway".MOLECULAR MEDICINE REPORTS 11.2(2015). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论